1. A summary of the current drug interaction guidance from the European Medicines Agency and considerations of future updates. Issue 1 (February 2020) Authors: Cole, Susan; Kerwash, Essam; Andersson, Anita Journal: Drug metabolism and pharmacokinetics Issue: Volume 35:Issue 1(2020) Page Start: 2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Commentary on the MID3 Good Practices Paper. (22nd July 2017) Authors: Manolis, Efthymios; Brogren, Jacob; Cole, Susan; Hay, Justin L.; Nordmark, Anna; Karlsson, Kristin E.; Lentz, Frederike; Benda, Norbert; Wangorsch, Gaby; Pons, Gerard; Zhao, Wei; Gigante, Valeria; Serone, Francesca; Standing, Joseph F.; Dokoumetzidis, Aris; Vakkilainen, Juha; van den Heuvel, Mich... Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 7(2017) Page Start: 416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Development and partial validation of a mouse model for predicting drug hypersensitivity reactions. (April 2014) Authors: Whritenour, Jessica; Cole, Susan; Zhu, Xu; Li, Dingzhou; Kawabata, Thomas T. Journal: Journal of immunotoxicology Issue: Volume 11:Number 2(2014) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EMA Review of Daunorubicin and Cytarabine Encapsulated in Liposomes (Vyxeos, CPX‐351) for the Treatment of Adults with Newly Diagnosed, Therapy‐Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia‐Related Changes. (13th April 2020) Authors: Tzogani, Kyriaki; Penttilä, Karri; Lapveteläinen, Tuomo; Hemmings, Robert; Koenig, Janet; Freire, João; Márcia, Silva; Cole, Susan; Coppola, Paola; Flores, Beatriz; Barbachano, Yolanda; Roige, Silvia Domingo; Pignatti, Francesco Journal: Oncologist Issue: Volume 25:Number 9(2020) Page Start: e1414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. European regulatory perspective on pediatric physiologically based pharmacokinetic models. (May 2017) Authors: Cole, Susan; Hay, Justin L; Luzon, Elisa; Nordmark, Anna; Rusten, Ine Skottheim Journal: International journal of pharmacokinetics Issue: Volume 2:Number 2(2017) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacokinetic Characterization to Enable Medicine Use in Pregnancy, the Potential Role of Physiologically‐Based Pharmacokinetic Modeling: A Regulatory Perspective. (27th August 2020) Authors: Cole, Susan; Coppola, Paola; Kerwash, Essam; Nooney, Janet; Lam, Siu Ping Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 9:Number 10(2020) Page Start: 547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The Use of Pregnancy Physiologically Based Pharmacokinetic Modeling for Renally Cleared Drugs. (15th September 2022) Authors: Coppola, Paola; Kerwash, Essam; Cole, Susan Other Names: Burckart Gilbert J. guestEditor.; van den Anker John guestEditor.; Dallmann André guestEditor. Journal: Journal of clinical pharmacology Issue: Volume 62(2022)Supplement 1 Page Start: S129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗